Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-005992-81Phase 3Completed
Phase 3, randomised, double-blind trial in coronary arteriosclerosis comparing Custodiol-N with Custodiol (2 arms). Primary endpoints: CK-MB area under the curve, Catecholamine requirement and 2 more. Started Aug 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-005992-81.